基于高精度三维重建的增强现实机器人辅助根治性前列腺切除术的影像与病理研究
本研究评估基于多参数磁共振成像(mpMRI)的高精度三维重建(HA3D™)及叠加成像在增强现实机器人辅助根治性前列腺切除术(AR-RARP)中的应用。30例前列腺癌患者入组,最终病理均确认索引病灶位置,疑似包膜外侵犯(ECE)的病理确认率为79%,三维虚拟重建与全标本扫描在前列腺>85%区域的偏差<3 mm。结果表明该技术可行且有助于个体化手术。
要点
- HA3D重建基于mpMRI数据,可在机器人手术中实时叠加虚拟图像指导手术。
- 最终病理在30/30例中确认索引病灶位置与金属夹标记一致。
- 疑似ECE的病理确认率为79%(15/19),神经血管束活检阳性率为73.3%(11/15)。
核心结论
- 基于mpMRI的HA3D虚拟重建与实时叠加成像可有效实施AR-RARP,有望通过个体化手术改善预后。
研究设计与样本
- 前瞻性单中心研究,纳入2017年6月至2018年4月间30例接受RARP的前列腺癌患者(cT1-3, cN0, cM0)。
- 根据mpMRI有无ECE分为A组(无ECE,11例,36.6%)和B组(有ECE,19例,63.4%)。
主要发现
- 最终病理在30/30例中确认索引病灶位于金属夹标记处。
- 疑似ECE经最终病理确认15/19例(79%)。
- AR引导的神经血管束选择性活检中11/15例(73.3%)阳性,确认ECE位置。
- 三维虚拟重建与全标本3D扫描的偏差在前列腺>85%的区域<3 mm。
临床怎么用
- AR-RARP可用于术中定位索引病灶,并在疑似ECE区域指导选择性活检和神经血管束处理。
- 术前mpMRI数据生成的三维虚拟模型可与内镜视频实时叠加,辅助手术决策。
局限性
- 样本量较小(30例),单中心研究,需更大规模验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the use of hyper-accuracy three-dimensional (HA3D™; MEDICS, Moncalieri, Turin, Italy) reconstruction based on multiparametric magnetic resonance imaging (mpMRI) and superimposed imaging during augmented-reality robot-assisted radical prostatectomy (AR-RARP). PATIENTS AND METHODS: Patients with prostate cancer (clinical stages cT1-3, cN0, cM0) undergoing RARP at our Centre, from June 2017 to April 2018, were enrolled. In all cases, cancer was diagnosed with targeted biopsy at the level of index lesion based on high-resolution (1-mm slices) mpMRI. HA3D reconstruction was created by dedicated software to obtain the 3D virtual model of the prostate and surrounding structures. A specific system was used to overlay virtual data on the endoscopic video displayed by the remote da Vinci® surgical console (Intuitive Surgical Inc., Sunnyvale, CA, USA), and the virtual images were superimposed by the surgeon by the means of the TilePro™ multi-input display technology (Intuitive Surgical Inc.). The AR technology was used in four standardised key steps during RARP. The procedures were modulated differently in cases of prostate cancer without extracapsular extension (ECE) at mpMRI (Group A) or in cases of prostate cancer with ECE (Group B) at mpMRI. In Group A, the virtual image of the prostate was overlaid on the endoscopic view and the intraprostatic lesion was marked on the prostate surface by a metallic clip at the level of the suspicious lesion as identified by the 3D virtual AR image. In Group B, the same step was performed; moreover, a metallic clip was placed at the level of the suspicious ECE on the neurovascular bundles (NVBs) according to the virtual images. Finally, selective biopsies were taken from the NVBs at this level, and then, the entire NVBs were removed for final pathological examination, according to standard clinical indications. For Group A, the pathologist performed a targeted needle biopsy at the level of the metallic clip on the surface of prostate before the sample reduction. For Group B, the presence of tumour was evaluated during the reduction phase, at the level of metallic clip on the prostate surface and at the level of NVBs, sent separately. Finally, an image 3D scanner (Kinect, Microsoft) was used to perform a dimensional comparison between the mpMRI-based 3D virtual reconstruction and the whole-mount specimen. RESULTS: In all, 30 patients were enrolled in the present study, 11 (36.6%) included in Group A and 19 (63.4%) in Group B. In all cases (30/30), final pathology confirmed the location of the index lesion, as cancer was found at the level of the metallic clip. The suspected ECE was confirmed on final pathology in 15/19 cases (79%). The AR-guided selective biopsies at the level of the NVBs confirmed the ECE location, with 11/15 (73.3%) biopsies at the level of NVBs positive for cancer. The mismatch between the 3D virtual reconstruction and the prostate 3D scanning based on the whole-mount specimen was <3 mm in >85% of the gland. CONCLUSION: Our results suggest that a HA3D virtual reconstruction of the prostate based on mpMRI data and real-time superimposed imaging allow performance of an effective AR-RARP. Potentially, this approach translates into better outcomes, as the surgeon can tailor the procedure for each patient.
引用
- Porpiglia F, Checcucci E, Amparore D, et al. Augmented-reality robot-assisted radical prostatectomy using hyper-accuracy three-dimensional reconstruction (HA3D™) technology: a radiological and pathological study. BJU Int. 2018. PMID: 30246936. doi:10.1111/bju.14549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。